C07D 403/00
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as
Official title: Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
C07D403/00 (Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as) appears on 18,626 US grants and 22,724 published applications in this corpus.
Search patents in C07D- Granted patents
- 18,626
- Published applications
- 22,724
- Assignees
- 4,848
- Inventors
- 42,944
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 28 | 0 |
| 1977 | 27 | 0 |
| 1978 | 19 | 0 |
| 1979 | 5 | 0 |
| 1980 | 4 | 0 |
| 1981 | 3 | 0 |
| 1982 | 7 | 0 |
| 1983 | 16 | 0 |
| 1984 | 28 | 0 |
| 1985 | 81 | 0 |
| 1986 | 78 | 0 |
| 1987 | 83 | 0 |
| 1988 | 91 | 0 |
| 1989 | 137 | 0 |
| 1990 | 133 | 0 |
| 1991 | 145 | 0 |
| 1992 | 154 | 0 |
| 1993 | 187 | 0 |
| 1994 | 180 | 0 |
| 1995 | 190 | 0 |
| 1996 | 243 | 0 |
| 1997 | 282 | 0 |
| 1998 | 275 | 0 |
| 1999 | 268 | 0 |
| 2000 | 208 | 0 |
| 2001 | 251 | 48 |
| 2002 | 327 | 318 |
| 2003 | 330 | 569 |
| 2004 | 285 | 788 |
| 2005 | 324 | 791 |
| 2006 | 428 | 715 |
| 2007 | 443 | 833 |
| 2008 | 392 | 841 |
| 2009 | 496 | 967 |
| 2010 | 671 | 1043 |
| 2011 | 626 | 1001 |
| 2012 | 737 | 897 |
| 2013 | 870 | 982 |
| 2014 | 927 | 979 |
| 2015 | 881 | 1054 |
| 2016 | 804 | 1100 |
| 2017 | 930 | 1018 |
| 2018 | 822 | 974 |
| 2019 | 838 | 1036 |
| 2020 | 789 | 1143 |
| 2021 | 706 | 979 |
| 2022 | 657 | 949 |
| 2023 | 600 | 1187 |
| 2024 | 558 | 1036 |
| 2025 | 615 | 865 |
| 2026 | 447 | 611 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- PHD inhibitor compounds, compositions, and use6 Oct 2026US 12,753,161 B2Akebia Therapeutics, Inc.
- Diaminopyrimidine carboxamide inhibitors of HPK16 Oct 2026US 12,753,163 B2Merck Sharp & Dohme Corp.
- Aminopyrimidine compounds6 Oct 2026US 12,753,165 B2Tyra Biosciences, Inc.
- Salt containing piperazine polycyclic derivative, crystal form thereof, preparation method therefor, and use thereof6 Oct 2026US 12,753,166 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Intermediate of biliverdin, and preparation method and use thereof6 Oct 2026US 12,753,167 B2Wuhan Jianmin Dapeng Pharmaceutical Co., Ltd.
- Trpv4 receptor ligands8 Oct 2026US 2026/0308120 A1University of Utah Research Foundation
- Heterocyclic carboxylic acid hydrazide ligand and use thereof in copper-catalyzed aryl halide coupling reaction8 Oct 2026US 2026/0308125 A1Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Antidegradant bis(dihydro and tetrahydroquinoline) compounds and uses thereof8 Oct 2026US 2026/0308127 A1Flexsys IP Holdings, LLC
- Bicyclic inhibitors of cbx chromodomains8 Oct 2026US 2026/0308130 A1Icahn School of Medicine at Mount Sinai
- Process for preparing xpo1 inhibitors and intermediates for use in the preparation of xpo1 inhibitors8 Oct 2026US 2026/0308132 A1Karyopharm Therapeutics Inc.
Most cited
By later US patents
- Pyrrolidine-containing monomers and oligomers675US 5,519,134 AIsis Pharmaceuticals, Inc. · 1996
- Pyrimidine derivatives and processes for the preparation thereof595US 5,521,184 ACiba-Geigy Corporation · 1996
- Methods for repairing damaged intervertebral discs571US 6,602,248 B1Arthro Care Corporation · 2003
- P38 inhibitors and methods of use thereof444US 7,799,782 B2Array BioPharma Inc. · 2010
- Methods for repairing damaged intervertebral discs418US 7,318,823 B2ArthroCare Corporation · 2008